Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Petrelintide at Different Concentrations in Participants With Overweight or Obesity
NCT07338214Phase 1Completed
- Sponsor
- Zealand Pharma
- Start
- Dec 2025
- Primary completion
- Mar 2026
- Modality
- Hormonal Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of petrelintide in obesity (4 arms), sponsored by Zealand Pharma. Primary endpoint: Pharmacokinetics. Started Dec 2025; status: completed.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07338214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07338214.